Back to Search
Start Over
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.
- Source :
-
The Lancet. Oncology [Lancet Oncol] 2007 Jul; Vol. 8 (7), pp. 658-60. - Publication Year :
- 2007
- Subjects :
- Antineoplastic Agents therapeutic use
Benzamides
Chromosome Aberrations
Chronic Disease
DNA Mutational Analysis
Genes, abl genetics
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Male
Middle Aged
Piperazines therapeutic use
Polymerase Chain Reaction
Pyrimidines therapeutic use
Janus Kinase 2 genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Mutation genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1470-2045
- Volume :
- 8
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The Lancet. Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 17613428
- Full Text :
- https://doi.org/10.1016/S1470-2045(07)70206-1